deltatrials
Completed PHASE2 NCT01005069

Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

Phase-II Clinical Study: A Randomized, Double Blind, Dose Ranging, and Controlled Study to Evaluate the Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

Sponsor: Dexa Medica Group

Conditions Diabetes Mellitus, Type 2
Interventions DLBS-32 Placebo capsule
Updated 5 times since 2017 Last updated: Sep 26, 2010 Started: Oct 31, 2009 Primary completion: Jul 31, 2010 Completion: Aug 31, 2010

This PHASE2 trial investigates Diabetes Mellitus, Type 2 and is currently completed. Dexa Medica Group leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dexa Medica Group
Data source: Dexa Medica Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Denpasar, Indonesia
  • • Jakarta Pusat, Indonesia